Rapid Health Technology Assessment on the Efficacy,Safety and Economy of Magnesium Isoglycyrrhizinate Injection in the Treatment of Drug-Induced Liver Injury
返回论文页
|更新时间:2022-10-08
|
Rapid Health Technology Assessment on the Efficacy,Safety and Economy of Magnesium Isoglycyrrhizinate Injection in the Treatment of Drug-Induced Liver Injury
WANG Chenping, Wang Dandan, Meng Jiajia, et al. Rapid Health Technology Assessment on the Efficacy,Safety and Economy of Magnesium Isoglycyrrhizinate Injection in the Treatment of Drug-Induced Liver Injury. [J]. 21(1):77-80(2021)
WANG Chenping, Wang Dandan, Meng Jiajia, et al. Rapid Health Technology Assessment on the Efficacy,Safety and Economy of Magnesium Isoglycyrrhizinate Injection in the Treatment of Drug-Induced Liver Injury. [J]. 21(1):77-80(2021) DOI: 10.14009/j.issn.1672-2124.2021.01.019.
Rapid Health Technology Assessment on the Efficacy,Safety and Economy of Magnesium Isoglycyrrhizinate Injection in the Treatment of Drug-Induced Liver Injury
OBJECTIVE: To systematically evaluate the efficacy
safety and economy of Magnesium isoglycyrrhizinate injection in the treatment of drug-induced liver injury( DILI). METHODS: Rapid health technology assessment method( HTA) was adopted
Pub Med
Cochrane Library
CRD Web
CNKI
Wanfang database were retrieved by two evaluators independently
HTA reports
system review/Meta-analysis and pharmacoeconomic studies about Magnesium isoglycyrrhizinate injection and control drugs in the treatment of DILI were enrolled
literature screen and quality evaluation were conducted according to the inclusion and exclusion criteria
then the conclusion was drawn after data extracting and comprehensive comparison. RESULTS: Totally 2 system review/Meta-analysis and 2 pharmacoeconomic studies were involved. In terms of the effectiveness in the treatment of DILI
the effective rate of magnesium isoglycyrrhizinate injection was better than that of tiopronin injection and diammonium glycyrrhizinate injection
and it had better effect on reducing alanine aminotransferase and aspartate aminotransferase than that of tiopronin injection
diammonium glycyrrhizinate injection
reduced glutathione injection and compound monoammonium glycyrrhizinate S injection
and it had only better effect on reducing total bilirubin and alkaline phosphatase than those of diammonium glycyrrhizinate injection; in terms of safety
the incidence of adverse drug reactions of magnesium isoglycyrrhizinate injection was lower than that of diammonium glycyrrhizinate injection and compound monoammonium glycyrrhizinate S injection; in terms of economy
magnesium isoglycyrrhizinate injection had a certain cost-effectiveness advantage in comparison with diammonium glycyrrhizinate injection and reduced glutathione injection. CONCLUSIONS: Magnesium isoglycyrrhizinate injection has good effect and safety in the treatment of DILI
which has certain economic advantages in my country.
关键词
异甘草酸镁注射液药物性肝损伤有效性安全性经济性快速卫生技术评估
Keywords
Magnesium isoglycyrrhizinate injectionDrug-induced liver injuryEfficacySafetyEconomyRapid health technology assessment
Propofol for Sedation During Gastrointestinal Endoscopy: A Rapid Health Technology Assessment
Rapid Health Technology Evaluation of Calcitriol in the Prevention and Treatment of Osteoporosis
Systematic Review of Efficacy and Safety of Sacubitril Valsartan in the Treatment of Hypertension
Efficacy and Safety of Compound Lactobacillus Acidophilus Combined with Different Antispasmodic Agents in the Treatment of Diarrhea Irritable Bowel Syndrome: A Systematic Review
Systematic Review of Efficacy and Safety of Cefoperazone Sulbactam in Obstetrics and Gynecology Infections
Related Author
HUO Xiuying
WANG Yang
LI Ting
PENG Wenping
TAN Ling
LUO Taimin
LI Shaoqiang
LI Ting
Related Institution
Dept.of Pharmacy,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Assessment of Clinical Drugs Risk and Individual Application Key Laboratory
Dept.of Anesthesiology,Beijing Hospital,National Center of Gerontology
Dept.of Pharmacy,Beijing Hospital,Assessment of Clinical Drugs Risk and Individual Application Key Laboratory,National Center of Gerontology,Chinese Academy of Medical Sciences
Dept.of Pharmacy, Zhongshan Hospital, Fudan University
Dept.of Pharmacy, Peking University Third Hospital